ENANTA PHARMACEUTICALS INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
Business Address 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Mailing Address 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Phone 617 607 0800
Fiscal Year End 0930
EIN 043205099
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 11, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
Annual Reports
10-K November 19, 2025
- Early wins in new RSV drug trials (EPN-104) showing potential superiority
- Progress in hepatitis B research addressing a 300 million patient unmet need
Insider Trading
SELL 7 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.